Cargando…
Plant-based vaccines against viruses
Plant-made or “biofarmed” viral vaccines are some of the earliest products of the technology of plant molecular farming, and remain some of the brightest prospects for the success of this field. Proofs of principle and of efficacy exist for many candidate viral veterinary vaccines; the use of plant-...
Autor principal: | |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4264547/ https://www.ncbi.nlm.nih.gov/pubmed/25465382 http://dx.doi.org/10.1186/s12985-014-0205-0 |
_version_ | 1782348762218233856 |
---|---|
author | Rybicki, Edward P |
author_facet | Rybicki, Edward P |
author_sort | Rybicki, Edward P |
collection | PubMed |
description | Plant-made or “biofarmed” viral vaccines are some of the earliest products of the technology of plant molecular farming, and remain some of the brightest prospects for the success of this field. Proofs of principle and of efficacy exist for many candidate viral veterinary vaccines; the use of plant-made viral antigens and of monoclonal antibodies for therapy of animal and even human viral disease is also well established. This review explores some of the more prominent recent advances in the biofarming of viral vaccines and therapies, including the recent use of ZMapp for Ebolavirus infection, and explores some possible future applications of the technology. |
format | Online Article Text |
id | pubmed-4264547 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2014 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-42645472014-12-13 Plant-based vaccines against viruses Rybicki, Edward P Virol J Review Plant-made or “biofarmed” viral vaccines are some of the earliest products of the technology of plant molecular farming, and remain some of the brightest prospects for the success of this field. Proofs of principle and of efficacy exist for many candidate viral veterinary vaccines; the use of plant-made viral antigens and of monoclonal antibodies for therapy of animal and even human viral disease is also well established. This review explores some of the more prominent recent advances in the biofarming of viral vaccines and therapies, including the recent use of ZMapp for Ebolavirus infection, and explores some possible future applications of the technology. BioMed Central 2014-12-03 /pmc/articles/PMC4264547/ /pubmed/25465382 http://dx.doi.org/10.1186/s12985-014-0205-0 Text en © Rybicki; licensee BioMed Central Ltd. 2014 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly credited. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated. |
spellingShingle | Review Rybicki, Edward P Plant-based vaccines against viruses |
title | Plant-based vaccines against viruses |
title_full | Plant-based vaccines against viruses |
title_fullStr | Plant-based vaccines against viruses |
title_full_unstemmed | Plant-based vaccines against viruses |
title_short | Plant-based vaccines against viruses |
title_sort | plant-based vaccines against viruses |
topic | Review |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4264547/ https://www.ncbi.nlm.nih.gov/pubmed/25465382 http://dx.doi.org/10.1186/s12985-014-0205-0 |
work_keys_str_mv | AT rybickiedwardp plantbasedvaccinesagainstviruses |